|4Jun 21, 12:41 PM ET

Ohr Pharmaceutical Inc 4

4 · Ohr Pharmaceutical Inc · Filed Jun 21, 2016

Insider Transaction Report

Form 4
Period: 2016-06-20
Backenroth Samuel
CEO & VP of Bus. Development
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2016-06-20$2.89/sh+10$29138,709 total
  • Purchase

    Common Stock, par value $0.0001 per share

    2016-06-20$2.88/sh+8$23138,717 total
  • Purchase

    Common Stock, par value $0.0001 per share

    2016-06-20$2.71/sh+200$542141,167 total
  • Purchase

    Common Stock, par value $0.0001 per share

    2016-06-20$2.87/sh+450$1,292139,167 total
  • Purchase

    Common Stock, par value $0.0001 per share

    2016-06-20$2.84/sh+1,800$5,112140,967 total

Documents

1 file
  • 4
    backenroth-form4_062016.xmlPrimary

    OWNERSHIP DOCUMENT